MeiraGTx Holdings PLC Cash Flow Conversion Efficiency
MeiraGTx Holdings PLC cash flow conversion efficiency. Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) has a cash flow conversion efficiency ratio of -0.179x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-38.54 Million) by net assets ($215.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MeiraGTx Holdings PLC (2016–2025)
Cash flow conversion efficiency of MeiraGTx Holdings PLC from 2016 to 2025. This chart illustrates how MeiraGTx Holdings PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for MeiraGTx Holdings PLC for real-time trading data and today's change.
MeiraGTx Holdings PLC Cash Flow Conversion Ratio Explained
MeiraGTx Holdings PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MeiraGTx Holdings PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MeiraGTx Holdings PLC ranked by their cash flow conversion efficiency. Also see MGTX market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Upbound Group Inc.
NASDAQ:UPBD
|
0.168x |
|
Svenska Handelsbanken AB (publ)
ST:SHB-B
|
0.330x |
|
Macquarie Technology Group Ltd
AU:MAQ
|
0.074x |
|
Shunfa Hengye Corp
SHE:000631
|
0.000x |
|
Shenzhen MYS Environmental Protection & Technology Co Ltd
SHE:002303
|
0.003x |
|
Amata Corporation Public Company Limited
BK:AMATA
|
0.047x |
|
Wuxi Xinhongye Wire & Cable Co. Ltd. A
SHE:301310
|
N/A |
|
Beijing Jingwei Hirain Technologies Co. Ltd. A
SHG:688326
|
-0.001x |
Annual Cash Flow Conversion Efficiency for MeiraGTx Holdings PLC (2016–2025)
The table below shows the annual cash flow conversion efficiency of MeiraGTx Holdings PLC from 2016 to 2025. Review MeiraGTx Holdings PLC free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-5.79 Million | $-46.36 Million | 8.003x | +619.44% |
| 2024-12-31 | $67.83 Million | $-104.50 Million | -1.541x | -102.04% |
| 2023-12-31 | $138.18 Million | $-105.36 Million | -0.763x | -22.82% |
| 2022-12-31 | $117.74 Million | $-73.10 Million | -0.621x | -993.13% |
| 2021-12-31 | $185.40 Million | $-10.53 Million | -0.057x | +78.82% |
| 2020-12-31 | $238.56 Million | $-63.97 Million | -0.268x | -355.23% |
| 2019-12-31 | $190.80 Million | $20.04 Million | 0.105x | +114.46% |
| 2018-12-31 | $81.06 Million | $-58.89 Million | -0.726x | -290.58% |
| 2017-12-31 | $-47.37 Million | $-18.06 Million | 0.381x | -54.53% |
| 2016-12-31 | $-17.14 Million | $-14.37 Million | 0.838x | -- |
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xe… Read more